PIK3CA and breast cancer: We then focused on breast cancer samples with PIK3CA mutations and observed that PIK3CA-mutant patients with high CDKN1A expression were associated with poorer overall patients survival compared to patients with mutant PI3K but lower CDKN1A levels (Fig. 4e).